LRMR

LRMR Change in Working Capital

$10.68MTTM · USD

Period ending:

LRMR FY Change in Working CapitalUSD
LRMR FY Change in Working Capital2011-12-31: $801.00K2012-12-31: $62.00K2013-12-31: -$1.63M2014-12-31: $815.00K2015-12-31: $6.73M2016-12-31: -$5.50M2017-12-31: -$99.00K2018-12-31: $593.00K2019-12-31: $226.00K2020-12-31: -$2.04M2021-12-31: $2.75M2022-12-31: $1.67M2023-12-31: -$2.51M2024-12-31: $6.18M2025-12-31: $47.10M$47.10M-$5.50M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LRMR change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Larimar Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
47,097,000
6,175,000
-2,511,000
1,669,000
2,747,000
-2,043,000
226,000
593,000
-99,000
-5,496,000
6,729,000
815,000
-1,634,000
62,000
801,000

Compare change in working capital

All LRMR financial metrics · LRMR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.